NCT05576818

Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease

Clinical Study Evaluating the Efficacy and Safety of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 66 (estimated)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 45 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study aims to investigate the possible efficacy and safety of synbiotic preparation of Lactobacillus acidophilus probiotic with prebiotic fibers as an adjuvant therapy in the treatment of Parkinson's disease

Conditions

• Parkinson's Disease

Interventions

Type	Name	Description
DRUG	Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers	Two sachets daily of synbiotic preparation containing Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers

Timeline

• Start date: 2022-06-30
• Primary completion: 2025-06-01
• Completion: 2025-06-01
• First posted: 2022-10-13
• Last updated: 2025-04-10

Locations

1 site across 1 country: Egypt